|
Originally published In Press as doi:10.1074/jbc.R000020200 on November 1, 2000
J. Biol. Chem., Vol. 276, Issue 2, 857-860, January 12, 2001
MINIREVIEW
Type II Transmembrane Serine Proteases
INSIGHTS INTO AN EMERGING CLASS OF CELL SURFACE PROTEOLYTIC
ENZYMES*
John D.
Hooper ,
Judith A.
Clements ,
James P.
Quigley§, and
Toni M.
Antalis¶
From the Centre for Molecular Biotechnology,
Queensland University of Technology, Gardens Point, Brisbane 4000, Australia, § The Scripps Research Institute, La Jolla,
California 92037, and the ¶ Cellular Oncology Laboratory,
University of Queensland and the Queensland Institute of Medical
Research, Brisbane 4029, Australia
 |
INTRODUCTION |
Cell surface proteolysis has emerged as an
important mechanism for the generation of biologically active proteins
that mediate a diverse range of cellular functions. The proteolytic
activities of membrane-anchored proteins, such as
ADAMs1 (1) and MT-MMPs (2),
are thought to play central roles in cell surface-activating events. In
contrast, most of the members of the serine protease family, one of the
oldest characterized and largest multigene proteolytic families, are
either secreted enzymes or sequestered in cytoplasmic storage
organelles awaiting signal-regulated release. These serine proteases
have well characterized roles in diverse cellular activities, including
blood coagulation, wound healing, digestion, and immune responses, as
well as tumor invasion and metastasis. However, during the last few
years there has been an explosion in the identification of
transmembrane proteins containing C-terminal extracellular serine
protease domains. These enzymes are ideally positioned to interact with
other proteins on the cell surface as well as soluble proteins, matrix
components, and proteins on adjacent cells. In addition, these
membrane-spanning proteases have cytoplasmic N-terminal domains,
suggesting possible functions in intracellular signal transduction.
This review delineates for the first time this emerging class of cell
surface proteolytic enzymes, the type II transmembrane serine proteases
(TTSPs), to highlight their structural features, expression profiles,
and possible roles in mediating cell surface proteolytic events.
 |
Structural Features of TTSPs |
In mammals the TTSPs currently consist of 17 members (Table
I), of which seven are found in man.
Enteropeptidase (also known as enterokinase) (3), because of its
essential role in the processing of digestive proteases, was the first
member of this group to be discovered nearly a century ago. The other
more recently identified members include hepsin (4), human airway
trypsin-like protease (HAT) (5), corin (6), MT-SP1 (7) (also known as
matriptase (8)), TMPRSS2 (9), and most recently
TMPRSS42 (10). The only
nonmammalian TTSP identified to date is the Drosophila
protease stubble-stubbloid (st-sb) (11). Mammalian orthologues have
been reported for enteropeptidase (mouse (12), rat (13), cow (14), and
pig (15)), hepsin (mouse (16) and rat (17)), corin (mouse, also known
as LRP4 (18)), MT-SP1 (mouse, also known as epithin (19)), and
TMPRSS2 (mouse, also known as epitheliasin (20)) (Table
I). The TTSPs share a number of common structural features including
(i) a proteolytic domain, (ii) a transmembrane domain, (iii) a short
cytoplasmic domain, and (iv) a variable length stem region containing
modular structural domains, which links the transmembrane and catalytic
domains (Fig. 1). It is this unique
combination of domains that suggests novel roles for the TTSPs at the
cell surface.
View this table:
[in this window]
[in a new window]
|
Table I
Summary of type II transmembrane serine proteases
The abbreviations used are: b, brain; bl, bladder; bp,
Drosophila 36-h pupae; c, colon; de, Drosophila
12-18-h embryo; dp, Drosophila early prepupae; e,
esophagus; h, heart; int, intestine; k, kidney; l, lung; le,
leukocytes; li, liver; p, pancreas; pl, placenta; pr, prostate; psi,
proximal small intestine (si); s, spleen; st, stomach; t, testes; th,
thymus; tr,
trachea.
|
|

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 1.
Type II transmembrane serine protease domain
structure. Structures, listed by length, are of the seven human
TTSPs and the Drosophila TTSP st-sb. The amino acid
(aa) sequence of each protein was scanned using the
ProfileScan algorithm to confirm the presence of each domain.
Numbers delineate the location of each domain.
|
|
Proteolytic Domains--
As is the case for the wider family of
enzymes of the chymotrypsin (S1)
fold,3 the proteolytic
domains of the TTSPs share a high degree of amino acid sequence
identity. In particular, the histidine, aspartate, and serine residues
necessary for catalytic activity are present in highly conserved
motifs. TTSPs are synthesized as single chain zymogens and are likely
activated by cleavage following an arginine or lysine present in a
highly conserved activation motif. Based on the predicted presence of a
conserved disulfide bond linking the pro- and catalytic domains (Fig.
1), the TTSPs are likely to remain membrane-bound following activation.
However, the isolation of soluble forms of enteropeptidase (21, 22),
HAT (23), and MT-SP1 (24) suggests that the extracellular domains of at least some of the TTSPs may also be shed from the cell surface. Other
cysteine residues conserved among the TTSPs include six cysteines
predicted to form three intraprotease domain disulfide bonds.
Enteropeptidase and hepsin each have one and corin has two additional
predicted disulfide linkages within the catalytic domain. The
presence of an aspartate six residues before the catalytic serine,
which in the activated TTSP would be positioned at the bottom of the S1
substrate binding pocket, is indicative that all of the TTSPs have
preference for substrates containing an arginine or lysine in the P1
amino acid position (S1 and P1 designations are described (25)). The
cleavage specificities and candidate physiological substrates for some
of the TTSPs have been elucidated. The predicted cleavage specificity
following basic amino acids indicates that the TTSPs are likely to have
a degree of autocatalytic activity. Indeed truncated mouse hepsin
lacking cytoplasmic and transmembrane domains (16) and the human MT-SP1
proteolytic domain (7) are capable of autoactivation. In contrast,
bovine enteropeptidase has extremely low autocatalytic activity (26). Interestingly, the proteolytic domain of bovine enteropeptidase has an
additional role in the targeting of enteropeptidase to the apical
membrane of enterocytes (27).
Transmembrane Domains--
Each of the TTSPs contains a
hydrophobic domain near the N terminus. This domain is predicted to
span the plasma membrane in such a way that the proteolytic domain lies
extracellularly, presumably to localize TTSP proteolytic activity in
close proximity to target substrates and/or to permit regulated release
of the protein from the cell surface. Cell surface localization has
been experimentally demonstrated for enteropeptidase, hepsin (28, 29),
MT-SP1 (30, 31), TMPRSS2 (20), and TMPRSS3 (10).
Cytoplasmic Domains--
The cytoplasmic domains of the TTSPs
(Fig. 1) range in length from 12 amino acids for HAT to 112 amino acids
for murine corin. Whether these domains have the potential to support
interactions with cytoskeletal components and signaling molecules is
not yet known. However, a number of the TTSPs including corin, MT-SP1, st-sb, and TMPRSS2 contain consensus phosphorylation sites for either
or both of protein kinase C and casein kinase II. In addition, based on
the cellular sorting of other integral membrane proteins (32) it is
likely that the cytoplasmic and transmembrane domains also contribute
to the targeting of the TTSPs to a particular cell surface in
polarized cells.
Stem Regions--
The stem regions of the TTSPs contain as
many as 11 structural domains that may serve as regulatory and/or
binding domains (Fig. 1). These include low density lipoprotein (LDL)
receptor class A domains, Group A scavenger receptor (SR) domains,
frizzled domains, Cls/Clr, urchin embryonic
growth factor and bone morphogenic protein 1 (CUB) domains,
sea urchin sperm protein, enterokinase, agrin (SEA) domains, a meprin, A5
antigen, and receptor protein phosphatase µ (MAM) domain,
and a disulfide knotted domain. Hepsin is the only TTSP that does not
possess an identified structural domain within its stem region.
Although functional roles for individual stem region domains have not
been demonstrated, the stem region of bovine enteropeptidase has been
shown to be required for efficient cleavage of its physiological
substrate trypsinogen (26). In addition, the N terminus of the stem
region of this protein is required for delivery of enteropeptidase to
the apical surface of polarized Madin-Darby canine kidney cells
(27).
The most common stem region structural domain is the LDL receptor
class A domain: corin contains eight, MT-SP1 four, enteropeptidase two,
and TMPRSS2 and TMPRSS4 one each (Fig. 1). Although the function of
these domains in the TTSPs has not been demonstrated, in other proteins
they bind Ca2+ ions and mediate the internalization of
macromolecules including serine protease·inhibitor complexes and
lipoproteins (33-35). In addition, although LDL receptor domains also
function in the uptake of LDLs, increased LDL uptake could not be
demonstrated following expression of murine corin in COS cells
(18).
Six other structural domains that are thought to be involved in
protein-protein interactions or protein-ligand interactions are found
in various TTSPs. SR domains (36) are present in corin, enteropeptidase, TMPRSS2, and TMPRSS3; frizzled domains (37) are
present in corin; CUB domains (38) are present in enteropeptidase and
MT-SP1; SEA domains (39) are present in HAT and enteropeptidase; a MAM
domain (40) is present in enteropeptidase; and a disulfide knotted
domain (41) is present in st-sb (Fig. 1). In addition to these
structural domains, human and mouse MT-SP1s possess a conserved RGD
motif (42) present in the first CUB domain. Interestingly, truncated
human MT-SP1 lacking cytoplasmic and transmembrane domains remains
bound to the cell surface of COS cells (31). Binding may be mediated
via an interaction between the MT-SP1 RGD motif and an integrin protein
or another cell surface protein. Alternatively, the mode of attachment
could be via a direct link such as a hydrocarbon chain.
 |
Tissue Expression of TTSPs |
Although a few of the TTSPs are expressed across several tissue
and cell types, in general these enzymes demonstrate relatively restricted expression patterns, indicating that they may have tissue-specific functions (Table I). Enteropeptidase shows a very
narrow expression pattern, being restricted in normal tissues to
enterocytes of the proximal small intestine (12). Corin expression is
also quite specific, with corin mRNA highly expressed in human heart (6) and corin protein expression localized to cardiac myocytes
(43). HAT is predominantly expressed in trachea (5, 23). Human TMPRSS2
expression is predominantly associated with prostate (9,
44).4 Hepsin, originally
identified from liver, is highly expressed in fetal liver and kidney
(45). Hepsin mRNA has been reported to be overexpressed by ovarian
tumors (46), and protein expression has been localized to tumor cell
membranes in renal cell carcinoma (29). TMPRSS4 has only recently
been characterized and was identified as a consequence of its strong
up-regulation in pancreatic tumors (10). While TMPRSS4 was not detected
in normal pancreas, very low level TMPRSS4 mRNA expression was
detected in tissues of the gastrointestinal tract and in some tissues
of the urogenital tract (10). MT-SP1 was originally identified from
a human breast cancer line (30) but shows the broadest pattern of
expression of the TTSPs being detected in a wide range of both human
(7) and murine tissues (19).
 |
Biochemical Data and Pathophysiological Roles |
The majority of the TTSPs have been identified relatively recently
and consequently have not been extensively characterized. Enteropeptidase is somewhat of an exception. Although the enzymatic activity ascribed to enteropeptidase was first identified almost a
century ago (47) it has been only recently that the complete amino acid
sequence was described (3). Enteropeptidase functions near the apex of
the digestive enzymatic cascade activating the digestive protease
trypsinogen to trypsin, which subsequently activates other enzymes
including chymotrypsinogen, proelastase, prolipases, and
procarboxypeptidases. Enteropeptidase possesses extremely low
autocatalytic activity, and it has been proposed that the serine
protease duodenase, secreted by duodenal epitheliocytes, may be its
physiological activator (48). Active enteropeptidase consists of heavy
and light chains that are extensively glycosylated (27, 49). It has
recently been reported that physiological concentrations of pancreatic
trypsin activate protease-activated receptor (PAR) 2 at the apical
membrane of enterocytes (50). PAR2 is a member of the PAR family of
signal-transducing, G protein-coupled, plasma membrane-spanning
receptors, which are activated by the proteolytic action of select
serine proteases (51, 52). These data and the observation that an
exosite in the heavy chain of enteropeptidase is required for efficient
recognition of trypsinogen (26) suggest that enteropeptidase may play a
role in facilitating trypsin-mediated PAR2 activation on enterocytes.
Thus enteropeptidase may localize trypsinogen/trypsin at the membrane
of enterocytes, initiating a limited proteolytic cascade at the cell
surface in close proximity to the trypsin cleavage target PAR2, thereby
facilitating receptor activation and signal transduction.
Hepsin is a glycoprotein originally cloned from human liver and
hepatoma cell lines and, more recently, implicated in mammalian cell
growth and morphology (53), tumor progression (28), and developmental
processes, such as blastocyst hatching (16). The importance of hepsin
in vivo, however, remains unclear as homozygous hepsin null
mice are phenotypically normal (54). An as yet unexplained phenotype of
the hepsin / mice is a 2-fold higher serum concentration of
bone-derived alkaline phosphatase compared with wild type mice (55).
The human airway TTSP, HAT, was originally purified as a soluble
protein from the sputum of patients with chronic airway diseases. Full-length HAT is synthesized, translocated to the cell surface where
it is processed to a soluble form, and then released from tracheal
serous glands as part of the host immune defense system (5).
Significantly, the human heart TTSP, corin, is an in vitro
activator of pro-atrial natriuretic peptide (ANP), a cardiac
hormone essential for the regulation of blood pressure (56), suggesting that corin is the long sought pro-ANP convertase. This proteolytic cleavage is critical for the regulation of ANP activity (57); thus,
corin may well prove to be an important factor in the regulation of
major cardiovascular diseases. Dysfunctional corin was proposed to be a
candidate for the rare congenital heart disease, total anomalous
pulmonary venous return (TAPVR), as the corin gene colocalizes to the
TAPVR locus on human chromosome 4p12-13 (6). In addition to heart,
murine corin is expressed by chondrocytes in a differentiation stage-specific manner during mouse development, suggesting that this
protease may play a role during chondrocyte differentiation/bone formation (6). However, while human and murine corin share high
homology, common structural features, expression profiles, and syntenic
chromosomal locations, these proteases are variant in the lengths of
their cytoplasmic domains (45 residues in human and 112 in mouse) and
show no conservation in amino acid sequence in this domain. This may
indicate that murine and human corin have different but perhaps
overlapping species-specific roles, or alternatively the cytoplasmic
domain is not essential for corin functions.
In other significant recent experiments it has been shown that MT-SP1
may be involved in initiating signaling and proteolytic cascades via
the activation of the cell surface-associated proteins PAR2 and pro-uPA
(31). Interestingly, MT-SP1 from breast cancer cells is detected
largely as an uncomplexed protein, whereas in milk it is present mainly
as a complex with the Kunitz-type serine protease inhibitor hepatocyte
growth factor inhibitor-1 (24). It will be important to identify the
inhibitor binding domains of MT-SP1 and the function of the
protease·inhibitor complex.
TMPRSS2 and TMPRSS4 have been identified through association with
cancer. TMPRSS2 is thought to play a role in epithelial cell biology,
and its association with prostate carcinogenesis has led to the
proposal that it may be a diagnostic or therapeutic target for prostate
cancer (44). TMPRSS2 has been proposed to be part of an enzymatic
cascade involving the serine proteases prostate-specific antigen
and human kallikrein K2 in a manner analogous to the fibrinolytic and
blood coagulation cascades (44). TMPRSS4 is overexpressed in pancreatic
cancers; however, its functional significance remains unclear (10).
The Drosophila serine protease st-sb is one of a number of
proteases involved in fly morphogenesis (11) and has a proteolytic function in detaching imaginal disks from extracellular matrices. In addition, the phenotype of st-sb mutants has led to speculation that
the encoded protein is involved in outside to inside signal transduction via its cytoplasmic domain, thus resulting in cytoskeletal reorganization and changes in cell shape during morphogenesis (11).
 |
Analogous Membrane-associated Proteolytic Systems |
In contrast to the traditional protein catabolic functions of many
of the secreted members of the serine protease family and based on the
presence of multiple structural domains in the TTSPs, it is tantalizing
to speculate that the TTSPs function as key regulators of signaling
events at the plasma membrane. Precedents for such functions come from
other more well characterized membrane-associated proteolytic systems
such as the ADAMs (1), the MT-MMPs (2), and the uPA·uPA receptor
system (58).
The ADAMs have recognized and proposed roles in the proteolysis of
extracellular matrix (ECM) components and cell surface proteins, in
mediating cell adhesion via integrin binding, in cell fusion and
signaling via interactions of their cytoplasmic domains, and in
RGD-mediated interactions with integrins (59-61). The TTSPs are
similarly positioned at the plasma membrane to release ECM
components and to proteolytically activate cell surface proteins such
as PARs, growth factors, and cytokines, and to interact with cell
surface and soluble ligands. In addition, the presence of the
cytoplasmic domains indicates that the TTSPs may be capable of
interacting with the cytoskeleton and/or with cellular signaling molecules.
The MT-MMPs function in pericellular cascades to activate other
MMPs involved in the cleavage of ECM components. The TTSPs may well
perform similar functions in activating proteolytic cascades on the
plasma membrane. Indeed, this function has been demonstrated for
enteropeptidase in the activation of digestive proteases. Moreover,
there is increasing evidence for cross-talk between proteolytic
systems. The uPA·uPA receptor system of cell surface-localized proteolytic activity has a recognized role in the initial stage of MMP
activation (62), and other serine proteases are also capable of
in vitro MMP activation (63, 64). The TTSPs could play a
direct role in MMP activation or an indirect role in localizing and
activating other serine proteases more directly associated with MMP
activation. The activation of uPA by MT-SP1 (31) and subsequent
downstream MMP activation could be an example of such cross-talk.
Several other parallels may also be drawn from the uPA·uPA receptor
system. That the TTSPs are directly anchored to the plasma membrane
implies that they have potential to mimic localization of the
uPA·uPAR system to the leading edge of migrating tumor cells (65).
Further, the interaction of the uPA·uPAR system, via a nonproteolytic
mechanism, in mediating cell-cell contacts through association with
integrins may also parallel TTSP properties. Indeed the multidomain
structure of the TTSPs indicates their capacity to interact with
multiple partners and suggests the possibility that these membrane
proteins may form part of a signalosome-like complex, thereby mediating
at the cell surface multiple signaling pathways as is the case for the
uPA·uPAR system (58).
 |
Concluding Remarks |
What is known about the TTSPs is that they function or have
the structural motifs necessary to function as serine proteases. What
can be speculated upon is that their numerous and varied nonproteolytic
domains are likely to mediate interactions with proteolytic substrates
and inhibitors as well as other proteins and ligands. Such interactions
will potentially regulate the proteolytic activity of the catalytic
domain but perhaps may also have functions quite independent of this
domain. Furthermore, given the integral plasma membrane nature of the
TTSPs, it is tempting to speculate that at least some of the TTSPs will
function directly in transducing signals across the plasma membrane, as
has been suggested for the Drosophila TTSP st-sb (11).
There is clearly a need for a greater understanding of the biology and
physiological functions of this group of unique proteases to obtain a
better picture of the dynamics occurring on the cell surface. Because
of the mosaic structure of the TTSPs it will be important to understand
the role of their individual domains as well as the role of each
protein in toto.
 |
Note Added in Proof |
Two cDNAs encoding the putative TTSPs
Xesp-2 and XMT-SP1 have recently been identified from Xenopus
laevis (67).
 |
FOOTNOTES |
To whom correspondence should be addressed. Tel.:
617-3362-0312; Fax: 617-3362-0107; E-mail: toniA@qimr.edu.au.
Published, JBC Papers in Press, November 1, 2000, DOI 10.1074/jbc.R000020200
3
Information on the classification and
nomenclature of the S1 family of peptidases can be found in the
Internet-accessible MEROPS data base.
4
The Northern blot data reported (9) are
incorrectly labeled due to inversion of the membranes (Stylianos
Antonarakis, personal communication).
2
Originally designated TMPRSS3 (10). The Human
Genome Nomenclature Committee-approved symbol TMPRSS3 has been
allocated to a predicted TTSP-encoding gene located on chromosome
21q22.3 (66). The amino acid sequence of the TMPRSS3 protein has not
been reported.
This minireview will be reprinted in the 2001 Minireviw Compendium,
which will be available in December, 2001. This work was supported by
the National Health and Medical Research Council of Australia, the
Queensland Cancer Fund, and the National Institutes of Health.
 |
ABBREVIATIONS |
The abbreviations used are:
ADAM, a
disintegrin-like and
metalloproteinase;
ANP, atrial natriuretic peptide;
CUB, Cls/Clr, urchin embryonic growth factor and
bone morphogenetic protein 1;
ECM, extracellular matrix;
HAT, human airway trypsin-like protease;
LDL, low density lipoprotein;
MAM, meprin, A5 antigen, and receptor protein
phosphatase µ;
MT-MMP, membrane-type matrix
metalloproteinase;
PAI-1, plasminogen activator inhibitor-1;
PAR, protease-activated receptor;
SEA, sea urchin sperm
protein-enterokinase-agrin;
SR, Group A
scavenger receptor;
st-sb, stubble-stubbloid;
TAPVR, total anomalous
pulmonary venous return;
TTSP, type II transmembrane serine protease;
uPA, urokinase-type plasminogen activator;
uPAR, uPA receptor.
 |
REFERENCES |
| 1.
|
Stone, A. L.,
Kroeger, M.,
and Sang, Q. X.
(1999)
J. Protein Chem.
18,
447-465
|
| 2.
|
Seiki, M.
(1999)
APMIS
107,
137-143
|
| 3.
|
Kitamoto, Y.,
Veile, R. A.,
Donis-Keller, H.,
and Sadler, J. E.
(1995)
Biochemistry
34,
4562-4568
|
| 4.
|
Leytus, S. P.,
Loeb, K. R.,
Hagen, F. S.,
Kurachi, K.,
and Davie, E. W.
(1988)
Biochemistry
27,
1067-1074
|
| 5.
|
Yamaoka, K.,
Masuda, K.,
Ogawa, H.,
Takagi, K.,
Umemoto, N.,
and Yasuoka, S.
(1998)
J. Biol. Chem.
273,
11895-11901
|
| 6.
|
Yan, W.,
Sheng, N.,
Seto, M.,
Morser, J.,
and Wu, Q.
(1999)
J. Biol. Chem.
274,
14926-14935
|
| 7.
|
Takeuchi, T.,
Shuman, M. A.,
and Craik, C. S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11054-11061
|
| 8.
|
Lin, C.-Y.,
Anders, J.,
Johnson, M.,
Sang, Q. A.,
and Dickson, R. B.
(1999)
J. Biol. Chem.
274,
18231-18236
|
| 9.
|
Paoloni-Giacobino, A.,
Chen, H.,
Peitsch, M. C.,
Rossier, C.,
and Antonarakis, S. E.
(1997)
Genomics
44,
309-320
|
| 10.
|
Wallrapp, C.,
Hahnel, S.,
Muller-Pillasch, F.,
Burghardt, B.,
Iwamura, T.,
Ruthenburger, M.,
Lerch, M. M.,
Adler, G.,
and Gress, T. M.
(2000)
Cancer Res.
60,
2602-2606
|
| 11.
|
Appel, L. F.,
Prout, M.,
Abu-Shumays, R.,
Hammonds, A.,
Garbe, J. C.,
Fristrom, D.,
and Fristrom, J.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
4937-4941
|
| 12.
|
Yuan, X.,
Zheng, X.,
Lu, D.,
Rubin, D. C.,
Pung, C. Y.,
and Sadler, J. E.
(1998)
Am. J. Physiol.
274,
G342-G349
|
| 13.
|
Yahagi, N.,
Ichinose, M.,
Matsushima, M.,
Matsubara, Y.,
Miki, K.,
Kurokawa, K.,
Fukamachi, H.,
Tashiro, K.,
Shiokawa, K.,
Kageyama, T.,
Takahashi, T.,
Inoue, H.,
and Takahashi, K.
(1996)
Biochem. Biophys. Res. Commun.
219,
806-812
|
| 14.
|
Kitamoto, Y.,
Yuan, X.,
Wu, Q.,
McCourt, D. W.,
and Sadler, J. E.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7588-7592
|
| 15.
|
Matsushima, M.,
Ichinose, M.,
Yahagi, N.,
Kakei, N.,
Tsukada, S.,
Miki, K.,
Kurokawa, K.,
Tashiro, K.,
Shiokawa, K.,
Shinomiya, K.,
Umeyama, H.,
Inoue, H.,
Takahashi, T.,
and Takahashi, H.
(1994)
J. Biol. Chem.
269,
19976-19982
|
| 16.
|
Vu, T. K. H.,
Liu, R. W.,
Haaksma, C. J.,
Tomasek, J. J.,
and Howard, E. W.
(1997)
J. Biol. Chem.
272,
31315-31320
|
| 17.
|
Farley, D.,
Reymond, F.,
and Nick, H.
(1993)
Biochim. Biophys. Acta
1173,
350-352
|
| 18.
|
Tomita, Y.,
Kim, D. H.,
Magoori, K.,
Fujino, T.,
and Yamamoto, T. T.
(1998)
J. Biochem. (Tokyo)
124,
784-789
|
| 19.
|
Kim, M. G.,
Chen, C.,
Lyu, M. S.,
Cho, E. G.,
Park, D.,
Kozak, C.,
and Schwartz, R. H.
(1999)
Immunogenetics
49,
420-428
|
| 20.
|
Jacquinet, E.,
Rao, N. V.,
Rao, G. V.,
and Hoidal, J. R.
(2000)
FEBS Lett.
468,
93-100
|
| 21.
|
Louvard, D.,
Maroux, S.,
Baratti, J.,
and Desnuelle, P.
(1973)
Biochim. Biophys. Acta
309,
127-137
|
| 22.
|
Fonseca, P.,
and Light, A.
(1983)
J. Biol. Chem.
258,
14516-14520
|
| 23.
|
Yasuoka, S.,
Ohnishi, T.,
Kawano, S.,
Tsuchihashi, S.,
Ogawara, M.,
Masuda, K.,
Yamaoka, K.,
Takahashi, M.,
and Sano, T.
(1997)
Am. J. Respir. Cell Mol. Biol.
16,
300-308
|
| 24.
|
Lin, C.-Y.,
Anders, J.,
Johnson, M.,
and Dickson, R. B.
(1999)
J. Biol. Chem.
274,
18237-18242
|
| 25.
|
Schechter, I.,
and Berger, A.
(1967)
Biochem. Biophys. Res. Commun.
27,
157-162
|
| 26.
|
Lu, D.,
Yuan, X.,
Zheng, X.,
and Sadler, J. E.
(1997)
J. Biol. Chem.
272,
31293-31300
|
| 27.
|
Zheng, X.,
Lu, D.,
and Sadler, J. E.
(1999)
J. Biol. Chem.
274,
1596-1605
|
| 28.
|
Kazama, Y.,
Hamamoto, T.,
Foster, D. C.,
and Kisiel, W.
(1995)
J. Biol. Chem.
270,
66-72
|
| 29.
|
Zacharski, L. R.,
Ornstein, D. L.,
Memoli, V. A.,
Rousseau, S. M.,
and Kisiel, W.
(1998)
Thromb. Haemostasis
79,
876-877
|
| 30.
|
Lin, C.-Y.,
Wang, J. K.,
Torri, J.,
Dou, L.,
Sang, Q. A.,
and Dickson, R. B.
(1997)
J. Biol. Chem.
272,
9147-9152
|
| 31.
|
Takeuchi, T.,
Harris, J.,
Huang, W.,
Yan, K. W.,
Coughlin, S. R.,
and Craik, C. S.
(2000)
J. Biol. Chem.
275,
26333-26342
|
| 32.
|
Keller, P.,
and Simons, K.
(1997)
J. Cell Sci.
110,
3001-3009
|
| 33.
|
Brown, M. S.,
Herz, J.,
and Goldstein, J. L.
(1997)
Nature
388,
629-630
|
| 34.
|
Nykjcer, A.,
Conese, M.,
Christensen, E. I.,
Olson, D.,
Cremona, O.,
Glieman, J.,
and Blasi, F.
(1997)
EMBO J.
16,
2610-2620
|
| 35.
|
Kounnas, M. Z.,
Church, F. C.,
Argraves, W. S.,
and Strickland, D. K.
(1996)
J. Biol. Chem.
271,
6523-6529
|
| 36.
|
Resnick, D.,
Chatterton, J. E.,
Schwartz, K.,
Slayter, H.,
and Krieger, M.
(1996)
J. Biol. Chem.
271,
26924-26930
|
| 37.
|
Cadigan, K. M.,
and Nusse, R.
(1997)
Genes Dev.
11,
3286-3305
|
| 38.
|
Bork, P.,
and Beckmann, G.
(1993)
J. Mol. Biol.
231,
539-545
|
| 39.
|
Bork, P.,
and Patthy, L.
(1995)
Protein Sci.
4,
1421-1425
|
| 40.
|
Beckmann, G.,
and Bork, P.
(1993)
Trends Biochem. Sci.
18,
40-41
|
| 41.
|
Muta, T.,
Hashimoto, R.,
Miyata, T.,
Nishimura, H.,
Toh, Y.,
and Iwanaga, S.
(1990)
J. Biol. Chem.
265,
22426-22433
|
| 42.
|
Hynes, R. O.
(1992)
Cell
69,
11-25
|
| 43.
|
Hooper, J. D.,
Scarman, A. L.,
Clarke, B. E.,
Normyle, J. F.,
and Antalis, T. M.
(2000)
Eur. J. Biochem.
267,
6931-6937
|
| 44.
|
Lin, B.,
Ferguson, C.,
White, J. T.,
Wang, S.,
Vessella, R.,
True, L. D.,
Hood, L.,
and Nelson, P. S.
(1999)
Cancer Res.
59,
4180-4184
|
| 45.
|
Tsuji, A.,
Torres-Rosado, A.,
Arai, T.,
Le Beau, M. M.,
Lemons, R. S.,
Chou, S. H.,
and Kurachi, K.
(1991)
J. Biol. Chem.
266,
16948-16953
|
| 46.
|
Tanimoto, H.,
Yan, Y.,
Clarke, J.,
Korourian, S.,
Shigemasa, K.,
Parmley, T. H.,
Parham, G. P.,
and O'Brien, T. J.
(1997)
Cancer Res.
57,
2884-2887
|
| 47.
| Pavlov, I. P. (1902) The Work of the Digestive Glands,
1st Ed., pp. 148-163, translated by W. H. Thompson, Charles
Griffin & Co., London
|
| 48.
|
Zamolodchikova, T. S.,
Sokolova, E. A.,
Lu, D.,
and Sadler, J. E.
(2000)
FEBS Lett.
466,
295-299
|
| 49.
|
Lu, D.,
and Sadler, J. E.
(1998)
in
Handbook of Proteolytic Enzymes
(Barrett, A. J.
, Rawlings, N. D.
, and Woessner, J. F., eds)
, pp. 50-54, Academic Press Ltd., London
|
| 50.
|
Kong, W.,
McConalogue, K.,
Khitin, L. M.,
Hollenberg, M. D.,
Payan, D. G.,
Bohm, S. K.,
and Bunnett, N. W.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8884-8889
|
| 51.
|
Dery, O.,
and Bunnett, N. W.
(1999)
Biochem. Soc. Trans.
27,
246-254
|
| 52.
|
Hollenberg, M. D.
(1999)
Trends Pharmacol. Sci.
20,
271-273
|
| 53.
|
Torres-Rosado, A.,
O'Shea, K. S.,
Tsuji, A.,
Chou, S. H.,
and Kurachi, K.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
7181-7185
|
| 54.
|
Wu, Q., Yu, D.,
Post, J.,
Halks, M. M.,
Sadler, J. E.,
and Morser, J.
(1998)
J. Clin. Invest.
101,
321-326
|
| 55.
|
Kawamura, S.,
Kurachi, S.,
Deyashiki, Y.,
and Kurachi, K.
(1999)
Eur. J. Biochem.
262,
755-764
|
| 56.
|
Yan, W.,
Wu, F.,
Morser, J.,
and Wu, Q.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
8525-8529
|
| 57.
|
Lang, R. E.,
Tholken, H.,
Ganten, D.,
Luft, F. C.,
Ruskoaho, H.,
and Unger, T.
(1985)
Nature
314,
264-266
|
| 58.
|
Koshelnick, Y.,
Ehart, M.,
Stockinger, H.,
and Binder, B. R.
(1999)
Thromb. Haemostasis
82,
305-311
|
| 59.
|
Wolfsberg, T. G.,
Primakoff, P.,
Myles, D. G.,
and White, J. M.
(1995)
J. Cell Biol.
131,
275-278
|
| 60.
|
Wolfsberg, T. G.,
and White, J. M.
(1996)
Dev. Biol.
180,
389-401
|
| 61.
|
Schlondorff, J.,
and Blobel, C. P.
(1999)
J. Cell Sci.
112,
3603-3617
|
| 62.
|
Carmeliet, P.,
Moons, L.,
Lijnen, R.,
Baes, M.,
Lemaitre, V.,
Tipping, P.,
Drew, A.,
Eeckhout, Y.,
Shapiro, S.,
Lupu, F.,
and Collen, D.
(1997)
Nat. Genet.
17,
439-444
|
| 63.
|
Nagase, H.,
Enghild, J. J.,
Suzuki, K.,
and Salvesen, G.
(1990)
Biochemistry
29,
5783-5789
|
| 64.
|
Ramos-DeSimone, N.,
Hahn-Dantona, E.,
Sipley, J.,
Nagase, H.,
French, D. L.,
and Quigley, J. P.
(1999)
J. Biol. Chem.
274,
13066-13076
|
| 65.
|
Blasi, F.
(1999)
Thromb. Haemostasis
82,
298-304
|
| 66.
|
Hattori, M.,
et al..
(2000)
Nature
405,
311-319
|
| 67.
|
Yamada, K.,
Takabatake, T.,
and Takeshima, K.
(2000)
Gene (Amst.)
252,
209-216
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. A. Swystun, B. Renaux, F. Moreau, S. Wen, M. A. Peplowski, M. D. Hollenberg, and W. K. MacNaughton
Serine proteases decrease intestinal epithelial ion permeability by activation of protein kinase C{zeta}
Am J Physiol Gastrointest Liver Physiol,
July 1, 2009;
297(1):
G60 - G70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Ramsay, J. D. Hooper, A. R. Folgueras, G. Velasco, and C. Lopez-Otin
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis
Haematologica,
June 1, 2009;
94(6):
840 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Szabo, P. Kosa, K. List, and T. H. Bugge
Loss of Matriptase Suppression Underlies Spint1 Mutation-Associated Ichthyosis and Postnatal Lethality
Am. J. Pathol.,
June 1, 2009;
174(6):
2015 - 2022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iolascon, L. De Falco, and C. Beaumont
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis
Haematologica,
March 1, 2009;
94(3):
395 - 408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wang, X. Liao, K. Fukuda, S. Knappe, F. Wu, D. L. Dries, J. Qin, and Q. Wu
Corin Variant Associated With Hypertension and Cardiac Hypertrophy Exhibits Impaired Zymogen Activation and Natriuretic Peptide Processing Activity
Circ. Res.,
August 29, 2008;
103(5):
502 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Ramsay, Y. Dong, M. L. Hunt, M. Linn, H. Samaratunga, J. A. Clements, and J. D. Hooper
Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs): KLK4 AND PAR-2 ARE CO-EXPRESSED DURING PROSTATE CANCER PROGRESSION
J. Biol. Chem.,
May 2, 2008;
283(18):
12293 - 12304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kojima, S. Tsuzuki, T. Fushiki, and K. Inouye
Roles of Functional and Structural Domains of Hepatocyte Growth Factor Activator Inhibitor Type 1 in the Inhibition of Matriptase
J. Biol. Chem.,
February 1, 2008;
283(5):
2478 - 2487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liao, W. Wang, S. Chen, and Q. Wu
Role of Glycosylation in Corin Zymogen Activation
J. Biol. Chem.,
September 21, 2007;
282(38):
27728 - 27735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-S. Lee, I-C. Tseng, Y. Wang, K.-i. Kiyomiya, M. D. Johnson, R. B. Dickson, and C.-Y. Lin
Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain
Am J Physiol Cell Physiol,
July 1, 2007;
293(1):
C95 - C105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Parr, A. J. Sanders, G. Davies, T. Martin, J. Lane, M. D. Mason, R. E. Mansel, and W. G. Jiang
Matriptase-2 Inhibits Breast Tumor Growth and Invasion and Correlates with Favorable Prognosis for Breast Cancer Patients
Clin. Cancer Res.,
June 15, 2007;
13(12):
3568 - 3576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. I. Gorodeski
Estrogen Decrease in Tight Junctional Resistance Involves Matrix-Metalloproteinase-7-Mediated Remodeling of Occludin
Endocrinology,
January 1, 2007;
148(1):
218 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Kilpatrick, R. L. Harris, K. A. Owen, R. Bass, C. Ghorayeb, A. Bar-Or, and V. Ellis
Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase
Blood,
October 15, 2006;
108(8):
2616 - 2623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bottcher, T. Matrosovich, M. Beyerle, H.-D. Klenk, W. Garten, and M. Matrosovich
Proteolytic Activation of Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium
J. Virol.,
October 1, 2006;
80(19):
9896 - 9898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ghersi, Q. Zhao, M. Salamone, Y. Yeh, S. Zucker, and W.-T. Chen
The Protease Complex Consisting of Dipeptidyl Peptidase IV and Seprase Plays a Role in the Migration and Invasion of Human Endothelial Cells in Collagenous Matrices.
Cancer Res.,
May 1, 2006;
66(9):
4652 - 4661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-A. Xuan, D. Schneider, P. Toy, R. Lin, A. Newton, Y. Zhu, S. Finster, D. Vogel, B. Mintzer, H. Dinter, et al.
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Cancer Res.,
April 1, 2006;
66(7):
3611 - 3619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Andreasen, G. Vuagniaux, N. Fowler-Jaeger, E. Hummler, and B. C. Rossier
Activation of Epithelial Sodium Channels by Mouse Channel Activating Proteases (mCAP) Expressed in Xenopus Oocytes Requires Catalytic Activity of mCAP3 and mCAP2 but not mCAP1
J. Am. Soc. Nephrol.,
April 1, 2006;
17(4):
968 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Hammonds and J. W. Fristrom
Mutational Analysis of Stubble-stubbloid Gene Structure and Function in Drosophila Leg and Bristle Morphogenesis
Genetics,
March 1, 2006;
172(3):
1577 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Kim, C. Heinlein, R. C. Hackman, and P. S. Nelson
Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease
Mol. Cell. Biol.,
February 1, 2006;
26(3):
965 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Saleem, V. M. Adhami, W. Zhong, B. J. Longley, C.-Y. Lin, R. B. Dickson, S. Reagan-Shaw, D. F. Jarrard, and H. Mukhtar
A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2006;
15(2):
217 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Matsushima, A. Takahashi, Y. Nakaya, H. Maezawa, M. Miki, Y. Nakamura, F. Ohgushi, and S. Yasuoka
Human airway trypsin-like protease stimulates human bronchial fibroblast proliferation in a protease-activated receptor-2-dependent pathway
Am J Physiol Lung Cell Mol Physiol,
February 1, 2006;
290(2):
L385 - L395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Dries, R. G. Victor, J. E. Rame, R. S. Cooper, X. Wu, X. Zhu, D. Leonard, S.-I. Ho, Q. Wu, W. Post, et al.
Corin Gene Minor Allele Defined by 2 Missense Mutations Is Common in Blacks and Associated With High Blood Pressure and Hypertension
Circulation,
October 18, 2005;
112(16):
2403 - 2410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Oberst, L.-Y. L. Chen, K.-I. Kiyomiya, C. A. Williams, M.-S. Lee, M. D. Johnson, R. B. Dickson, and C.-Y. Lin
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease
Am J Physiol Cell Physiol,
August 1, 2005;
289(2):
C462 - C470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-S. Lee, K.-i. Kiyomiya, C. Benaud, R. B. Dickson, and C.-Y. Lin
Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells
Am J Physiol Cell Physiol,
April 1, 2005;
288(4):
C932 - C941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tang, M. Kmet, L. Corral, S. Vartanian, A. Tobler, and J. Papkoff
Testisin, a Glycosyl-Phosphatidylinositol-Linked Serine Protease, Promotes Malignant Transformation In vitro and In vivo
Cancer Res.,
February 1, 2005;
65(3):
868 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Hobson, S. Netzel-Arnett, R. Szabo, S. M. Rehault, F. C. Church, D. K. Strickland, D. A. Lawrence, T. M. Antalis, and T. H. Bugge
Mouse DESC1 Is Located within a Cluster of Seven DESC1-like Genes and Encodes a Type II Transmembrane Serine Protease That Forms Serpin Inhibitory Complexes
J. Biol. Chem.,
November 5, 2004;
279(45):
46981 - 46994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Knappe, F. Wu, M. R. Madlansacay, and Q. Wu
Identification of Domain Structures in the Propeptide of Corin Essential for the Processing of Proatrial Natriuretic Peptide
J. Biol. Chem.,
August 13, 2004;
279(33):
34464 - 34471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-H. Lin, G.-W. Chang, J. Q. Davies, M. Stacey, J. Harris, and S. Gordon
Autocatalytic Cleavage of the EMR2 Receptor Occurs at a Conserved G Protein-coupled Receptor Proteolytic Site Motif
J. Biol. Chem.,
July 23, 2004;
279(30):
31823 - 31832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Noel, C Maillard, N Rocks, M Jost, V Chabottaux, N E Sounni, E Maquoi, D Cataldo, and J M Foidart
Membrane associated proteases and their inhibitors in tumour angiogenesis
J. Clin. Pathol.,
June 1, 2004;
57(6):
577 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.-J. Hung, I.-W. J. Hsu, J. L. Dreiling, M.-J. Lee, C. A. Williams, M. D. Oberst, R. B. Dickson, and C.-Y. Lin
Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts
Am J Physiol Cell Physiol,
May 1, 2004;
286(5):
C1159 - C1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Suzuki, H. Kobayashi, N. Kanayama, Y. Saga, M. Suzuki, C.-Y. Lin, R. B. Dickson, and T. Terao
Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase
J. Biol. Chem.,
April 9, 2004;
279(15):
14899 - 14908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Hansen, M. Fassnacht, S. Hahner, F. Hammer, M. Schammann, S. R. Meyer, A. B. Bicknell, and B. Allolio
The Adrenal Secretory Serine Protease AsP Is a Short Secretory Isoform of the Transmembrane Airway Trypsin-Like Protease
Endocrinology,
April 1, 2004;
145(4):
1898 - 1905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chokki, S. Yamamura, H. Eguchi, T. Masegi, H. Horiuchi, H. Tanabe, T. Kamimura, and S. Yasuoka
Human Airway Trypsin-Like Protease Increases Mucin Gene Expression in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
April 1, 2004;
30(4):
470 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Knappe, F. Wu, M. R. Masikat, J. Morser, and Q. Wu
Functional Analysis of the Transmembrane Domain and Activation Cleavage of Human Corin: DESIGN AND CHARACTERIZATION OF A SOLUBLE CORIN
J. Biol. Chem.,
December 26, 2003;
278(52):
52363 - 52370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wu and Q. Wu
Corin-Mediated Processing of Pro-Atrial Natriuretic Peptide in Human Small Cell Lung Cancer Cells
Cancer Res.,
December 1, 2003;
63(23):
8318 - 8322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Bayer, S. R. Halsell, J. W. Fristrom, D. P. Kiehart, and L. von Kalm
Genetic Interactions Between the RhoA and Stubble-stubbloid Loci Suggest a Role for a Type II Transmembrane Serine Protease in Intracellular Signaling During Drosophila Imaginal Disc Morphogenesis
Genetics,
November 1, 2003;
165(3):
1417 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kirchhofer, M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J. M. Elliott, R. T. Corpuz, R. A. Lazarus, and P. Moran
Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1
J. Biol. Chem.,
September 19, 2003;
278(38):
36341 - 36349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cal, V. Quesada, C. Garabaya, and C. Lopez-Otin
Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product
PNAS,
August 5, 2003;
100(16):
9185 - 9190.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y J Lee, D Park, S Y Kim, and W J Park
Pathogenic mutations but not polymorphisms in congenital and childhood onset autosomal recessive deafness disrupt the proteolytic activity of TMPRSS3
J. Med. Genet.,
August 1, 2003;
40(8):
629 - 631.
[Full Text]
|
 |
|

|
 |

|
 |
 
Y.-M. Xiong, J. Chen, and L. Zhang
Modulation of CD11b/CD18 Adhesive Activity by Its Extracellular, Membrane-Proximal Regions
J. Immunol.,
July 15, 2003;
171(2):
1042 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Oberst, C. A. Williams, R. B. Dickson, M. D. Johnson, and C.-Y. Lin
The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor
J. Biol. Chem.,
July 11, 2003;
278(29):
26773 - 26779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wu, F. Wu, J. Pan, J. Morser, and Q. Wu
Furin-mediated Processing of Pro-C-type Natriuretic Peptide
J. Biol. Chem.,
July 3, 2003;
278(28):
25847 - 25852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Boonacker, S. Elferink, A. Bardai, B. Fleischer, and C. J.F. Van Noorden
Fluorogenic Substrate [Ala-Pro]2-Cresyl Violet But Not Ala-Pro-Rhodamine 110 Is Cleaved Specifically by DPPIV Activity: A Study in Living Jurkat Cells and CD26/DPPIV-transfected Jurkat Cells
J. Histochem. Cytochem.,
July 1, 2003;
51(7):
959 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Suzuki, H. Kobayashi, Y. Tanaka, Y. Hirashima, N. Kanayama, Y. Takei, Y. Saga, M. Suzuki, H. Itoh, and T. Terao
Bikunin Target Genes in Ovarian Cancer Cells Identified by Microarray Analysis
J. Biol. Chem.,
April 18, 2003;
278(17):
14640 - 14646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kalus, B. Schnegelsberg, N. G. Seidah, R. Kleene, and M. Schachner
The Proprotein Convertase PC5A and a Metalloprotease Are Involved in the Proteolytic Processing of the Neural Adhesion Molecule L1
J. Biol. Chem.,
March 14, 2003;
278(12):
10381 - 10388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bernocco, B. M. Steiglitz, D. I. Svergun, M. V. Petoukhov, F. Ruggiero, S. Ricard-Blum, C. Ebel, C. Geourjon, G. Deleage, B. Font, et al.
Low Resolution Structure Determination Shows Procollagen C-Proteinase Enhancer to be an Elongated Multidomain Glycoprotein
J. Biol. Chem.,
February 21, 2003;
278(9):
7199 - 7205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guipponi, G. Vuagniaux, M. Wattenhofer, K. Shibuya, M. Vazquez, L. Dougherty, N. Scamuffa, E. Guida, M. Okui, C. Rossier, et al.
The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro
Hum. Mol. Genet.,
November 1, 2002;
11(23):
2829 - 2836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Velasco, S. Cal, V. Quesada, L. M. Sanchez, and C. Lopez-Otin
Matriptase-2, a Membrane-bound Mosaic Serine Proteinase Predominantly Expressed in Human Liver and Showing Degrading Activity against Extracellular Matrix Proteins
J. Biol. Chem.,
September 27, 2002;
277(40):
37637 - 37646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vuagniaux, V. Vallet, N. F. Jaeger, E. Hummler, and B. C. Rossier
Synergistic Activation of ENaC by Three Membrane-bound Channel-activating Serine Proteases (mCAP1, mCAP2, and mCAP3) and Serum- and Glucocorticoid-regulated Kinase (Sgk1) in Xenopus Oocytes
J. Gen. Physiol.,
July 30, 2002;
120(2):
191 - 201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wu, W. Yan, J. Pan, J. Morser, and Q. Wu
Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes
J. Biol. Chem.,
May 3, 2002;
277(19):
16900 - 16905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yamaguchi, A. Okui, T. Yamada, H. Nakazato, and S. Mitsui
Spinesin/TMPRSS5, a Novel Transmembrane Serine Protease, Cloned from Human Spinal Cord
J. Biol. Chem.,
February 22, 2002;
277(9):
6806 - 6812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Mason, H.-P. Xu, S. K. Rao, A. Leask, M. Barcia, J. Shan, R. Stephenson, and S. Tabibzadeh
Lefty Contributes to the Remodeling of Extracellular Matrix by Inhibition of Connective Tissue Growth Factor and Collagen mRNA Expression and Increased Proteolytic Activity in a Fibrosarcoma Model
J. Biol. Chem.,
January 4, 2002;
277(1):
407 - 415.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E.-G. Cho, M. G. Kim, C. Kim, S.-R. Kim, I. S. Seong, C. Chung, R. H. Schwartz, and D. Park
N-terminal Processing Is Essential for Release of Epithin, a Mouse Type II Membrane Serine Protease
J. Biol. Chem.,
November 21, 2001;
276(48):
44581 - 44589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Friedrich, P. Fuentes-Prior, E. Ong, G. Coombs, M. Hunter, R. Oehler, D. Pierson, R. Gonzalez, R. Huber, W. Bode, et al.
Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase
J. Biol. Chem.,
January 11, 2002;
277(3):
2160 - 2168.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|